查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1291422

放射性皮炎市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

市场概述：

全球放射性皮炎市场规模在2022年达到4.819亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到5.979亿美元，在2023-2028年期间表现出3.5%的增长率（CAGR）。

放射性皮炎，或称辐射性皮炎，是指由于用于治疗癌症的放射疗法而引起的一种皮肤病。它通常作为癌症治疗期间或介入放射治疗后的副作用发生在乳房、肺部、皮肤、颈部、头部或会阴部癌症患者身上，因为皮肤是靶区的一部分。治疗放射性皮炎的一些常用产品包括局部抗生素、皮质类固醇、亲水乳膏、水凝胶和水胶体敷料、硅涂层敷料、银叶敷料、口服镇痛剂和消炎剂。近年来，放射性皮炎的治疗已经得到了重视，因为它有助于减少不适，尽量减少疼痛，防止正在进行的治疗中断，同时提高病人的整体生活质量。

放射性皮炎的市场趋势：

癌症的广泛流行和越来越多地采用放射疗法作为治疗选择，是推动市场增长的主要因素。除此以外，全球范围内老年人口的增加和应对放疗的不良副作用的需求不断增加，都增强了对放射性皮炎治疗的需求。此外，许多管理和非管理机构正在采取有利的倡议，传播有关现有放射性皮炎治疗和管理产品的意识。这一点，再加上公共和私人投资在生命科学领域正在进行的研究和开发（R&D）活动中的增加，正在催化市场的增长。此外，领先的企业正专注于开发创新的产品变体，以扩大其产品组合并获得竞争优势。此外，不断增加的临床试验、有利的政府政策、不断增加的消费能力、不断改善的医疗基础设施和容易获得的非专利药品，是创造积极市场前景的其他一些因素。

本报告回答的关键问题：

  • 2022年全球放射性皮炎市场的规模是多少？
  • 2023-2028年，全球放射性皮炎市场的预期增长率是多少？
  • COVID-19对全球放射性皮炎市场的影响是什么？
  • 推动全球放射性皮炎市场的关键因素是什么？
  • 基于产品的全球放射性皮炎市场的细分情况是什么？
  • 基于分销渠道的全球放射性皮炎市场的细分情况如何？
  • 全球放射性皮炎市场的主要地区有哪些？
  • 谁是全球放射性皮炎市场的主要参与者/公司？

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球放射性皮炎市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按产品分類的市场

  • 专题
    • 市场趋势
    • 关键领域
      • 皮质类固醇
      • 亲水性药膏
      • 抗生素
      • 其他
    • 市场预测
  • 口服
    • 市场趋势
    • 市场预测
  • 敷料
    • 市场趋势
    • 关键领域
      • 水凝胶和水胶体敷料
      • 无刺阻隔膜
      • 蜂蜜浸泡的纱布
      • 硅胶涂层敷料
      • 其他
    • 市场预测

第7章 ：按分销渠道分類的市场

  • 医院药房
    • 市场趋势
    • 市场预测
  • 零售药店
    • 市场趋势
    • 市场预测
  • 网上药店
    • 市场趋势
    • 市场预测

第8章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第九章：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十章：价值链分析

第十一章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十二章 ：价格分析

第十三章 ：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • 3M Company
    • Bausch Health Companies Inc.
    • Bayer AG
    • BMG PHARMA S.p.A.
    • Charles River Laboratories International Inc.
    • ConvaTec Group plc
    • Helsinn Healthcare SA
    • ICON plc
    • Integra LifeSciences
    • Molnlycke Health Care AB
    • Stratpharma AG
Product Code: SR112023A5638

Market Overview:

The global radiodermatitis market size reached US$ 481.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 597.9 Million by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient's life. 

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiodermatitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and distribution channel.

Breakup by Product:

  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Antibiotics
    • Others
  • Oral
  • Dressings
    • Hydrogel and Hydrocolloid Dressings
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressings
    • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Molnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report:

  • What was the size of the global radiodermatitis market in 2022?
  • What is the expected growth rate of the global radiodermatitis market during 2023-2028?
  • What has been the impact of COVID-19 on the global radiodermatitis market?
  • What are the key factors driving the global radiodermatitis market?
  • What is the breakup of the global radiodermatitis market based on the product?
  • What is the breakup of the global radiodermatitis market based on the distribution channel?
  • What are the key regions in the global radiodermatitis market?
  • Who are the key players/companies in the global radiodermatitis market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Radiodermatitis Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product

  • 6.1  Topical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Corticosteroids
      • 6.1.2.2 Hydrophilic Creams
      • 6.1.2.3 Antibiotics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2  Oral
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Dressings
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hydrogel and Hydrocolloid Dressings
      • 6.3.2.2 No Sting Barrier Film
      • 6.3.2.3 Honey Impregnated Gauze
      • 6.3.2.4 Silicone Coated Dressings
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7   Market Breakup by Distribution Channel

  • 7.1  Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Region

  • 8.1  North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2  Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3  Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4  Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5  Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9   SWOT Analysis

  • 9.1  Overview
  • 9.2  Strengths
  • 9.3  Weaknesses
  • 9.4  Opportunities
  • 9.5  Threats

10  Value Chain Analysis

11  Porters Five Forces Analysis

  • 11.1  Overview
  • 11.2  Bargaining Power of Buyers
  • 11.3  Bargaining Power of Suppliers
  • 11.4  Degree of Competition
  • 11.5  Threat of New Entrants
  • 11.6  Threat of Substitutes

12  Price Analysis

13  Competitive Landscape

  • 13.1  Market Structure
  • 13.2  Key Players
  • 13.3  Profiles of Key Players
    • 13.3.1  3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2  Bausch Health Companies Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3  Bayer AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4  BMG PHARMA S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5  Charles River Laboratories International Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6  ConvaTec Group plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7  Helsinn Healthcare SA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8  ICON plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9  Integra LifeSciences
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10  Molnlycke Health Care AB
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11  Stratpharma AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Radiodermatitis Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: North America: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: United States: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: China: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: India: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: France: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
  • Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
  • Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Radiodermatitis Market: Competitive Structure
  • Table 6: Global: Radiodermatitis Market: Key Players